Disclosures for "Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates"
-
Dr. Bunin has nothing to disclose.
-
Mr. Lee has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Mr. Lee has stock in Biohaven Pharmaceuticals.
-
Dr. Kazmierski has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Kazmierski has stock in Biohaven Pharmaceuticals. Dr. Kazmierski has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. McGrath has received personal compensation for serving as an employee of Biohaven. Ms. McGrath has stock in Biohaven.
-
Ms. ROSSI has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. ROSSI has stock in Biohaven Pharmaceuticals. Ms. ROSSI has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Nicholson has received personal compensation for serving as an employee of Biohaven. Dr. Nicholson has stock in Biohaven.
-
Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Morrison & Foerster LLP. Gene Dubowchik has stock in Biohaven Pharmaceuticals.
-
Dr. Dierks has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Dierks has received personal compensation for serving as an employee of BMS. Dr. Dierks has stock in Biohaven Pharmaceuticals. Dr. Dierks has stock in BMS.
-
Dr. Sharpe has nothing to disclose.
-
Dr. Pirman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Pirman has received personal compensation for serving as an employee of Agios Pharmaceuticals. Dr. Pirman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scaffold Therapeutics. Dr. Pirman has stock in Biohaven. Dr. Pirman has stock in Agios.
-
Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Biohaven. Dr. Car has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Agios Pharmaceuticals. Dr. Car has stock in biohaven. Dr. Car has stock in Agios.
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
-
Prof. Spiegel has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Biohaven Pharmaceuticals. Prof. Spiegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Magnet Biomedicine. Prof. Spiegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Kymera Therapeutics. Prof. Spiegel has stock in Biohaven Pharmaceuticals. Prof. Spiegel has stock in Magnet biomedicine. Prof. Spiegel has stock in Kymera Therapeutics. The institution of Prof. Spiegel has received research support from Biohaven Pharmaceuticals. Prof. Spiegel has received intellectual property interests from a discovery or technology relating to health care.